Offshore Driller with $7.5 Backlog Inspires Stock Surge
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
Worldwide Dividend Etf Performance 5 Year
Review Worldwide Dividend ETF Performance 5 Year to gauge long-term resilience, consistency, and income potential.
24,171 articles
Republic Services 2026 Earnings: Q1 Outlook for Investors
As Republic Services reveals Q1 2026 figures, investors gain a window into revenue growth, margins, and cash flow. Th...
Ixj: Pure Pharma Against—A Global Healthcare Bet Today
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Nordson (NDSN) 2025 Earnings Outlook and Analysis
Nordson (NDSN) is set for a pivotal 2025 earnings year. This guide breaks down the levers that could move profits, ho...
Stock Hold Through Decade: Top Oil Stock to Buy and Hold
Oil remains a core part of global energy, and a patient, rules-based approach can reward investors. This article buil...
Energy Stocks Secretly Better in Turbulent Markets
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
Plains GP Holdings Buy Signals Confidence in Outlook
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
The Portfolio That Pays Season Tickets Forever, Explained
Fans and retirees are turning dividend income into a lifelong fund for season-ticket renewals. Experts warn about tax...
Elanco (ELAN) 2025 Earnings: What Investors Should Know
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
Why IBM Rallied Today: The Big Break in AI and Quantum
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...
General Mills, Mattel, Mohawk: Hidden-Value Contrarian Bets
As markets swing, a trio of unloved names—general mills, mattel, and mohawk—are drawing renewed attention from retire...
It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status